Title: Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101
Title: A synthetic chloride channel restores chloride conductance in human cystic fibrosis epithelial cells.
Journal: PloS one 20120101
Title: Exciting new clinical trials in cystic fibrosis: infants need not apply.
Journal: American journal of respiratory and critical care medicine 20110615
Title: Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
Journal: Journal of medicinal chemistry 20110428
Title: Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.
Journal: American journal of respiratory and critical care medicine 20110301
Title: Hitting the target: new treatments for cystic fibrosis.
Journal: American journal of respiratory and critical care medicine 20101215
Title: Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
Journal: Pediatric pulmonology 20100201
Title: Emerging treatments in cystic fibrosis.
Journal: Drugs 20091001
Title: Update in cystic fibrosis 2008.
Journal: American journal of respiratory and critical care medicine 20090315
Title: Drug developers aim to treat cystic fibrosis through disease modification.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081215
Title: Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.
Journal: Pulmonary pharmacology & therapeutics 20080801
Title: Novel agents in cystic fibrosis.
Journal: Nature reviews. Drug discovery 20080701
Title: Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis.
Journal: Current opinion in pharmacology 20080601
Title: Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20080301
Title: Expression profiling after retinal detachment and reattachment: a possible role for aquaporin-0.
Journal: Investigative ophthalmology & visual science 20080201
Title: Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.
Journal: American journal of respiratory and critical care medicine 20070815
Title: Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
Journal: Pediatric pulmonology 20050401
Title: P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice.
Journal: Investigative ophthalmology & visual science 20031001
Title: Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease.
Journal: Advanced drug delivery reviews 20021205
Title: The P2Y(2) receptor agonist INS37217 stimulates RPE fluid transport in vitro and retinal reattachment in rat.
Journal: Investigative ophthalmology & visual science 20021101
Title: Effect of INS37217, a P2Y(2) receptor agonist, on experimental retinal detachment and electroretinogram in adult rabbits.
Journal: Investigative ophthalmology & visual science 20021101
Title: Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis.
Journal: The Journal of pharmacology and experimental therapeutics 20020901
Title: Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits.
Journal: Advances in experimental medicine and biology 20020101
